GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Cyclically Adjusted PS Ratio

Celltrion (XKRX:068270) Cyclically Adjusted PS Ratio : 18.38 (As of Jun. 05, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Celltrion Cyclically Adjusted PS Ratio?

As of today (2024-06-05), Celltrion's current share price is ₩188100.00. Celltrion's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩10,232.70. Celltrion's Cyclically Adjusted PS Ratio for today is 18.38.

The historical rank and industry rank for Celltrion's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:068270' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 14.12   Med: 37.08   Max: 94.33
Current: 17.22

During the past years, Celltrion's highest Cyclically Adjusted PS Ratio was 94.33. The lowest was 14.12. And the median was 37.08.

XKRX:068270's Cyclically Adjusted PS Ratio is ranked worse than
80.16% of 504 companies
in the Biotechnology industry
Industry Median: 5.525 vs XKRX:068270: 17.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Celltrion's adjusted revenue per share data for the three months ended in Mar. 2024 was ₩3,556.718. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩10,232.70 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Celltrion Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Celltrion's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Cyclically Adjusted PS Ratio Chart

Celltrion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.24 61.31 27.92 19.23 20.25

Celltrion Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.07 16.74 14.34 20.25 18.69

Competitive Comparison of Celltrion's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Celltrion's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celltrion's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celltrion's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Celltrion's Cyclically Adjusted PS Ratio falls into.



Celltrion Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Celltrion's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=188100.00/10232.7
=18.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celltrion's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Celltrion's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3556.718/118.8477*118.8477
=3,556.718

Current CPI (Mar. 2024) = 118.8477.

Celltrion Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1,135.492 99.353 1,358.294
201409 736.842 99.608 879.166
201412 854.275 99.098 1,024.527
201503 690.423 99.720 822.856
201506 1,165.023 100.050 1,383.911
201509 1,059.206 100.110 1,257.459
201512 1,299.576 100.220 1,541.126
201603 720.602 100.560 851.650
201606 1,216.894 100.790 1,434.915
201609 1,105.526 101.460 1,294.985
201612 1,691.015 101.560 1,978.862
201703 1,325.177 102.850 1,531.300
201706 1,665.437 102.610 1,928.987
201709 1,568.098 103.490 1,800.800
201712 2,005.643 102.990 2,314.458
201803 1,647.952 104.100 1,881.415
201806 1,770.529 104.130 2,020.775
201809 1,558.618 105.650 1,753.319
201812 1,772.397 104.350 2,018.642
201903 1,453.013 104.490 1,652.668
201906 1,543.043 104.880 1,748.542
201909 1,896.773 105.200 2,142.843
201912 3,102.092 105.120 3,507.197
202003 2,518.608 105.540 2,836.183
202006 2,892.738 104.870 3,278.299
202009 3,693.415 106.200 4,133.276
202012 3,640.396 105.765 4,090.683
202103 3,075.802 107.357 3,405.007
202106 2,907.301 107.579 3,211.847
202109 2,708.004 108.759 2,959.198
202112 4,417.374 109.676 4,786.761
202203 3,535.344 111.806 3,758.012
202206 3,982.089 114.083 4,148.409
202209 4,323.909 114.831 4,475.144
202212 4,040.917 115.200 4,168.862
202303 4,176.345 116.550 4,258.693
202306 3,671.888 117.140 3,725.421
202309 4,731.449 119.111 4,720.982
202312 2,684.443 118.848 2,684.443
202403 3,556.718 118.848 3,556.718

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Celltrion  (XKRX:068270) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Celltrion Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Celltrion's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Celltrion (XKRX:068270) Business Description

Industry
Traded in Other Exchanges
N/A
Address
13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion (XKRX:068270) Headlines

No Headlines